The role of 5-hydroxymethyluracil in chronic lymphocytic leukemia development
2020/39/O/NZ5/00852
Keywords
Descriptors
- NZ5_001: Etiologia chorób człowieka
- NZ5_003: Patogeneza chorób człowieka
- NZ2_002: Genomika, transkryptomika i epigenomika
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny
Voivodeship: kujawsko-pomorskie
Principal investigator (from the host institution)
dr hab. Daniel Stefan Gackowski
Number of co-investigators in the project: 2
Call
PRELUDIUM BIS 2 – announced on 2020-09-15
- Amount awarded
- 541 680 PLN
- Project start date
- 2021-10-01
- Project end date
- 2026-09-30
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Articles in post-conference publications (1)
-
Levels of 5-hydroxymethyluracil in the DNA of Monoclonal B Lymphoma patients blood cells
- Authors:
- Bagińska, P., Starczak, M., Skalska-Bugała, A., Wasilów, A., Mijewski, P., Leśniewski, F., Wołowiec, A., Gackowska, L., Gawroński, M., Guz, J., Szpila, A., Zarakowska, E., Siomek-Górecka, A., Różalski, R., Gackowski, D., & Oliński, R.
- Conference:
- 1st Epigenetics Society International Meeting Epigenetics of Disease and Development (year: 2023, volume: Epigenetics of Disease and Development, pages: 148-150), Publisher: Frontiers
- Date:
- conference 12-14 Oct 2023
- Status:
- Published
- DOI:
- 10.3389/978-2-8325-1235-7 – link to the publication